Wuhan Hvsen Biotechnology (300871.SZ) plans to launch an employee stock ownership plan in 2026.

Wuhan Hvsen Biotechnology (300871.SZ) disclosed the draft of the employee stock ownership plan for 2026. The total number of participants in the plan will not exceed 14 people and the planned fundraising amount will not exceed RMB 3.081 million. The subscription unit will be in "shares," with each share priced at RMB 1.00. The maximum number of shares for the employee stock ownership plan is 3.081 million. The stock for the employee stock ownership plan will come from the repurchased Wuhan Hvsen Biotechnology A shares in the company's special securities account. Once approved by the company's shareholders' meeting, the plan will acquire the company's shares held in the repurchased special securities account through legal means such as non-trading transfers. The total number of shares acquired by the employee stock ownership plan will not exceed 205,400 shares, accounting for 0.10% of the company's total share capital as of the announcement date of the employee stock ownership plan draft.